EVOLUS, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
EVOLUS, INC. (EOLS) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $697.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-05
- EVOLUS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $354.00K, a 14.56% increase year-over-year.
- EVOLUS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $343.00K, a 30.42% increase year-over-year.
- EVOLUS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $335.00K, a 40.76% increase year-over-year.
- EVOLUS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $330.00K, a 79.35% increase year-over-year.
- EVOLUS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $1.24M, a 71.09% increase from fiscal 2024.
- EVOLUS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $723.00K, a 1.50% decline from fiscal 2023.
- EVOLUS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $734.00K, a 5.29% decline from fiscal 2022.
- EVOLUS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $775.00K, a 11.99% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $354.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $697.00K 10-Q · filed 2026-08-05 | $1.03M derived: sum of 3 quarters · filed 2026-08-05 | $1.36M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $343.00K 10-Q · filed 2026-05-04 | $678.00K derived: sum of 2 quarters · filed 2026-05-04 | $1.01M derived: sum of 3 quarters · filed 2026-05-04 | $1.32M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $335.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $665.00K derived: sum of 2 quarters · filed 2026-03-03 | $974.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.24M 10-K · filed 2026-03-03 |
| 2025-09-30 | $330.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $639.00K derived: sum of 2 quarters · filed 2026-08-05 | $902.00K 10-Q · filed 2025-11-05 | $1.14M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $309.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $572.00K 10-Q · filed 2026-08-05 | $810.00K derived: sum of 3 quarters · filed 2026-08-05 | $994.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $263.00K 10-Q · filed 2026-05-04 | $501.00K derived: sum of 2 quarters · filed 2026-05-04 | $685.00K derived: sum of 3 quarters · filed 2026-05-04 | $838.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $238.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $422.00K derived: sum of 2 quarters · filed 2026-03-03 | $575.00K derived: sum of 3 quarters · filed 2026-03-03 | $723.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | $184.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $337.00K derived: sum of 2 quarters · filed 2025-11-05 | $485.00K 10-Q · filed 2025-11-05 | $629.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | $153.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $301.00K 10-Q · filed 2025-08-05 | $445.00K derived: sum of 3 quarters · filed 2026-03-03 | $611.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | $148.00K 10-Q · filed 2025-05-07 | $292.00K derived: sum of 2 quarters · filed 2026-03-03 | $458.00K derived: sum of 3 quarters · filed 2026-03-03 | $673.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | $144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $310.00K derived: sum of 2 quarters · filed 2026-03-03 | $525.00K derived: sum of 3 quarters · filed 2026-03-03 | $734.00K 10-K · filed 2026-03-03 |
| 2023-09-30 | $166.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $381.00K derived: sum of 2 quarters · filed 2024-11-06 | $590.00K 10-Q · filed 2024-11-06 | $792.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | $215.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $424.00K 10-Q · filed 2024-07-31 | $626.00K derived: sum of 3 quarters · filed 2025-03-04 | $823.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | $209.00K 10-Q · filed 2024-05-07 | $411.00K derived: sum of 2 quarters · filed 2025-03-04 | $608.00K derived: sum of 3 quarters · filed 2025-03-04 | $799.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | $202.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $399.00K derived: sum of 2 quarters · filed 2025-03-04 | $590.00K derived: sum of 3 quarters · filed 2025-03-04 | $775.00K 10-K · filed 2025-03-04 |
| 2022-09-30 | $197.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $388.00K derived: sum of 2 quarters · filed 2023-11-07 | $573.00K 10-Q · filed 2023-11-07 | $753.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $191.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $376.00K 10-Q · filed 2023-08-02 | $556.00K derived: sum of 3 quarters · filed 2023-08-02 | $732.00K derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $185.00K 10-Q · filed 2023-05-09 | $365.00K derived: sum of 2 quarters · filed 2023-05-09 | $541.00K derived: sum of 3 quarters · filed 2023-05-09 | $711.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $180.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $356.00K derived: sum of 2 quarters · filed 2023-03-08 | $526.00K derived: sum of 3 quarters · filed 2023-03-08 | $692.00K 10-K · filed 2023-03-08 |
| 2021-09-30 | $176.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $346.00K derived: sum of 2 quarters · filed 2022-11-08 | $512.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $170.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $336.00K 10-Q · filed 2022-08-02 | ||
| 2021-03-31 | $166.00K 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |